🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 03/12/1973 | 0,0093 USD |
| 31/08/1973 | 0,0078 USD |
| 05/06/1973 | 0,0078 USD |
| 05/03/1973 | 0,0078 USD |
| 05/12/1972 | 0,0078 USD |
| 09/06/1972 | 0,0073 USD |
| 02/03/1972 | 0,0073 USD |
| 06/12/1971 | 0,0073 USD |
| 03/09/1971 | 0,0073 USD |
| 07/06/1971 | 0,0073 USD |
| 02/03/1971 | 0,0073 USD |
| 01/12/1970 | 0,0073 USD |
| 02/09/1970 | 0,0066 USD |
| 02/06/1970 | 0,0066 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 05/07/2001 | 61,74 | 62,29 | 60,88 | 61,20 | -0,87% | 2,29% | 6.039.414 |
| 03/07/2001 | 62,02 | 62,02 | 61,57 | 61,74 | +0,54% | 0,72% | 4.248.697 |
| 02/07/2001 | 61,12 | 61,76 | 61,11 | 61,40 | +0,69% | 1,06% | 7.487.436 |
| 29/06/2001 | 62,40 | 62,64 | 60,73 | 60,98 | -1,68% | 3,06% | 10.473.083 |
| 28/06/2001 | 62,60 | 62,98 | 62,00 | 62,02 | -0,98% | 1,55% | 8.773.646 |
| 27/06/2001 | 63,36 | 63,65 | 62,63 | 62,63 | -0,88% | 1,60% | 7.983.664 |
| 26/06/2001 | 63,84 | 64,41 | 63,18 | 63,19 | -1,90% | 1,93% | 7.033.233 |
| 25/06/2001 | 65,12 | 65,49 | 63,74 | 64,41 | -0,44% | 2,68% | 7.129.334 |
| 22/06/2001 | 66,86 | 66,86 | 64,59 | 64,69 | -8,96% | 3,40% | 19.734.888 |
| 21/06/2001 | 71,71 | 71,80 | 70,61 | 71,06 | -0,25% | 1,66% | 4.312.939 |
| 20/06/2001 | 71,18 | 72,38 | 70,96 | 71,24 | +0,08% | 1,98% | 4.655.845 |
| 19/06/2001 | 70,52 | 71,18 | 70,13 | 71,18 | +0,47% | 1,49% | 3.917.634 |
| 18/06/2001 | 69,83 | 71,41 | 69,75 | 70,85 | +0,68% | 2,38% | 3.924.760 |
| 15/06/2001 | 70,52 | 71,13 | 69,85 | 70,37 | -0,20% | 1,81% | 8.442.583 |
| 14/06/2001 | 69,66 | 70,63 | 69,58 | 70,52 | +1,05% | 1,51% | 5.339.665 |
| 13/06/2001 | 68,65 | 70,32 | 68,24 | 69,78 | +0,72% | 3,03% | 5.037.422 |
| 12/06/2001 | 68,52 | 69,65 | 67,84 | 69,28 | +0,50% | 2,63% | 5.064.774 |
| 11/06/2001 | 70,13 | 70,31 | 68,61 | 68,94 | -2,65% | 2,44% | 4.531.552 |
| 08/06/2001 | 71,18 | 71,56 | 70,50 | 70,82 | -0,79% | 1,49% | 2.221.865 |
| 07/06/2001 | 70,40 | 71,44 | 70,39 | 71,38 | +1,16% | 1,49% | 4.204.786 |
| 06/06/2001 | 71,80 | 71,85 | 70,38 | 70,56 | -1,83% | 2,05% | 3.156.366 |
| 05/06/2001 | 71,07 | 72,03 | 70,31 | 71,88 | +1,36% | 2,43% | 4.377.706 |
| 04/06/2001 | 70,52 | 71,04 | 70,04 | 70,92 | +0,16% | 1,42% | 2.620.734 |
| 01/06/2001 | 68,70 | 71,10 | 68,70 | 70,80 | +1,66% | 3,49% | 5.066.451 |
| 31/05/2001 | 69,90 | 70,09 | 68,80 | 69,65 | -0,40% | 1,84% | 3.969.824 |
| 30/05/2001 | 70,98 | 70,98 | 69,71 | 69,92 | -1,49% | 1,79% | 5.210.132 |
| 29/05/2001 | 70,09 | 71,22 | 69,90 | 70,98 | +2,47% | 1,89% | 4.717.467 |
| 25/05/2001 | 69,32 | 69,97 | 68,78 | 69,27 | +0,14% | 1,72% | 3.747.229 |
| 24/05/2001 | 70,23 | 70,23 | 68,47 | 69,18 | -2,03% | 2,50% | 8.983.037 |
| 23/05/2001 | 71,76 | 72,00 | 69,53 | 70,61 | -1,46% | 3,44% | 7.660.146 |